ERBB2 and cervical squamous cell carcinoma: For instance, GTSF1L was upregulated in CESC with mutated CA125 or MAPK1 compared to the wild-type counterpart, while the expression of GTSF1L was reduced in the KRAS- or ERBB2-mutated CESC tumors (Figure 9C).